mirabegron wholesale supplier

Miratide 50 mg Mirabegron Extended Release Tablet | USA Supply Product Name: Miratide 50 mg Brand Name: Miratide Generic Name: Mirabegron Active Content Name: Mirabegron Composition: Mirabegron 50 mg Strength: 50 mg Dosage Form: Extended-Release Tablet Medicine Category: Urology Medicines Therapeutic Category: Overactive Bladder Management Drug Class: Beta-3 Adrenergic Receptor Agonist Route of Administration: Oral Understanding Mirabegron 50 mg Mirabegron is a medicine used for bladder-related conditions, particularly overactive bladder. Unlike antimuscarinic medicines, it works primarily by stimulating beta-3 adrenergic receptors in the bladder. The extended-release formulation is designed to release the medicine gradually rather than all at once. Tablets should therefore be taken according to the prescribing information and should not be crushed or altered unless the official product instructions specifically permit it. How Mirabegron Works During the bladder's storage phase, activation of beta-3 adrenergic receptors helps relax the detrusor smooth muscle. This can improve the bladder's ability to store urine and help manage symptoms associated with overactive bladder. What Makes the Extended-Release Formulation Important? Miratide is identified as an extended-release tablet. This formulation is intended to provide controlled release of the active ingredient over time. The tablet should be handled according to the original product label. Patients should not independently change the dosage, frequency, or tablet administration method. When Mirabegron May Be Prescribed Mirabegron may be prescribed for adults with overactive bladder symptoms such as urinary urgency, increased urinary frequency, and urge urinary incontinence. The appropriate indication and treatment plan should always be determined by a qualified healthcare professional. Possible Side Effects Reported adverse effects associated with mirabegron can include increased blood pressure, headache, urinary tract infection, and nasopharyngitis. Other reactions can occur, and patients experiencing persistent or unusual symptoms should seek medical advice. Major U.S. Markets Covered Professional pharmaceutical inquiries may be considered from businesses serving New York City, New York; Los Angeles, California; Chicago, Illinois; Houston, Texas; and Phoenix, Arizona, as well as other U.S. locations where applicable. FAQs 1. What is Miratide 50 mg? Miratide 50 mg is an extended-release tablet containing Mirabegron 50 mg, a medicine belonging to the beta-3 adrenergic receptor agonist class. 2. What therapeutic category does Miratide belong to? It falls under urology medicines, particularly medicines used for managing overactive bladder symptoms. 3. How does Mirabegron work in the bladder? Mirabegron activates beta-3 adrenergic receptors, helping the bladder muscle relax during the urine-storage phase. 4. What does “extended release” mean for Miratide? It means the formulation is designed to release the active ingredient gradually over an extended period. 5. Should Miratide extended-release tablets be crushed? Extended-release tablets generally need to be swallowed intact. The instructions on the specific product label or prescribing information should be followed. 6. Can Mirabegron affect blood pressure? Yes. Mirabegron can increase blood pressure in some patients, which is why monitoring may be appropriate during treatment. 7. What information should be checked on a Miratide pack? The pack should be reviewed for the active ingredient, strength, extended-release designation, manufacturer, batch number, expiry date, and storage instructions. 8. Is Mirabegron the same type of medicine as an antimuscarinic? No. Mirabegron works primarily as a beta-3 adrenergic receptor agonist and has a different mechanism from antimuscarinic bladder medicines. 9. Does the 50 mg strength determine how every patient should take Miratide? No. Treatment selection and dosing depend on individual clinical factors and should follow a healthcare professional's instructions and applicable prescribing information. 10. Why is Mirabegron classified as a beta-3 adrenergic receptor agonist? Mirabegron primarily works by activating beta-3 adrenergic receptors in the bladder, helping the detrusor muscle relax during the bladder-filling phase. Mirabegron 50mg Tablet, Mirabegron Extended Release Tablet 50mg, Mirabegron ER 50mg Tablet, Mirabegron Extended Release Tablets, Mirabegron 50mg ER, Mirabegron 50mg Wholesale Supplier, Mirabegron 50mg Bulk Supply, Mirabegron Tablet Exporter from India, Mirabegron ER Tablet Supplier.